ARN-75039

· Arisan Therapeutics, Inc.

Drug timelines are a Plus or Pro feature.

3 regulatory and trial events tracked for ARN-75039, covering 2025-05-18 to 2026-03-11. Get the full timeline:

Most recent: Clinical Trial Update: ARN-75039 Lassa Fever Treatment in West Africa [Phase 2]